Omission of Surgical Axillary Staging Noninferior To Sentinel Lymph Node Biopsy in Patients with cN0, T1 or T2 Invasive Breast Cancer By Ogkologos - January 14, 2025 932 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the INSEMA study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR GreaterGood’s Mask Donations Are Helping Wildlife Sanctuaries Continue Their Essential Work September 10, 2020 Adding Pembrolizumab to Docetaxel Does Not Significantly Improve Outcomes in Patients... April 9, 2025 COVID-19 May Have Saved a Woman’s Life by Helping Her Discover... June 24, 2021 Survivors of Childhood Cancer are at Excess Risk of Late Mortality... April 21, 2023 Load more HOT NEWS Adjuvant Dabrafenib Plus Trametinib Associated with Better RFS and DMFS than... First treatment approved in England for advanced bile duct cancer Adding Relacorilant To Nab-paclitaxel Prolongs Survival Compared with a Weekly Taxane... Active Surveillance for Low-Risk Prostate Cancer Continues to Rise
